ArticleJournal of conservative dentistry and endodontics2026
Newly developed universal supra-nano spherical filled resin composite in posterior teeth.
Article in Journal of conservative dentistry and endodontics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Context: There has been a tremendous leap in resin composite technology over the last two decades. "The rapid pace of product development means that detailed clinical data on individual materials are often limited, even when improved versions are regularly introduced". This clinical investigation examined the effectiveness of a recently created resin composite for back teeth, which is universal supra-nano spherical filled, using revised United States Public Health Service (USPHS) standards. Aims: In order to conduct a clinical evaluation and comparison of two resin composites - Omnichroma, a universal supra-nano spherical filled resin composite, and Harmonize, a universal nanohybrid composite resin in Class I posterior restorations over the course of 6 months. Materials and Methods: A randomized, double-blind, split-mouth clinical trial was conducted in 50 patients, each requiring two Class I occlusal restorations. In each patient, one cavity was restored with a universal supra-nano spherical composite resin (Omnichroma, Statistical Analysis Used: Frequencies and percentages were calculated, and Fisher's exact test was used for intergroup comparisons at each recall interval. Results: A 100% recall at 1 week, 1 month, 3 months, and 6 months was achieved since all 50 patients were present at every recall session. When it came to clinical performance, both Omnichroma and Harmonize were on par. values of Bravo (clinically acceptable) and Alpha (excellent) were given to the majority of restorations, while no Charlie (failure) values were recorded. For each memory metric, there were no statistically significant differences between the two materials ( Conclusions: Within the 6-month follow-up period, Omnichroma and Harmonize composite resins demonstrated comparable and clinically acceptable performance in Class I posterior restorations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.